MG
ARKG icon

Mather Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Mather Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4K Hold
770
– – ﹤0.01% 1216
2026
Q1 		$20.3K Buy
+770
New +$22.5K ﹤0.01% 1273
2025
Q4 		– Sell
-767
Closed -$21.3K – 700
2025
Q3 		$21.3K Buy
+767
New +$19.4K ﹤0.01% 1107
2025
Q2 		– Sell
-767
Closed -$15.9K – 671
2025
Q1 		$15.9K Hold
767
– – ﹤0.01% 1142
2024
Q4 		$18.1K Hold
767
– – ﹤0.01% 1109
2024
Q3 		$19.6K Sell
767
-57
-7% -$1.45K ﹤0.01% 1067
2024
Q2 		$23.7K Buy
824
+57
+7% +$1.44K ﹤0.01% 1227
2024
Q1 		$25.2K Buy
+767
New +$23.1K ﹤0.01% 1011

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mather Group's ARKG Position: Q2 2026 in Review

Mather Group held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 770 shares worth $32.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

Mather Group first reported a position in ARKG in Q1 2024 and has held it in 8 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Mather Group held 770 shares of ARK Genomic Revolution ETF worth $32.4K as of Q2 2026.
  • Mather Group left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1216 holding.
  • Mather Group first reported a position in ARK Genomic Revolution ETF in Q1 2024 and has held it in 8 quarters since.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.